BioSante Pharmaceuticals Inc. (BPAX) Announces Positive Leukemia Vaccine Results
Specialty pharmaceutical company BioSante Pharmaceuticals Inc. today announced positive results for their leukemia vaccine. The results of a human clinical study show that the company's GVAX leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec. All patients enrolled in the trial used Gleevec for at least one year and still had cancer cells present. In addition, the vaccine produced relatively few side effects. The research was funded by the National Institute of Health. The study was conducted by researchers at the John Hopkins Kimmel…